Clinical Trial Update: To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the tolerability and pharmacokinetics of TQB3142 injected in patients with advanced cancer; the study is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TQB3142 (TQB3142)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Malignant Tumors | Phase 1 | Status: NOT_YET_RECRUITING